Table 2.

Prognostic factors for DFS and OS by univariate analysis.

Variables	n	DFS			OS
		3 yrs	5 yrs	P	3 yrs	5 yrs	P
Gender
Male	166	30.7%	27.1%		49.4%	40.4%
Female	22	40.9%	40.9%	0.195	59.1%	54.5%	0.112
Age (years)
≤50	100	32.0%	27.0%		48.0%	39.0%
>50	88	34.1%	30.7%	0.282	53.4%	45.5%	0.334
HCC family history
Yes	18	27.8%	16.7%		55.6%	55.6%
No	170	32.9%	30.0%	0.451	50.0%	40.6%	0.226
HBsAg
Negative	28	46.4%	46.4%		67.9%	53.6%
Positive	160	29.4%	25.6%	0.030	47.5%	40.0%	0.073
AFP (ng/ml)
<200	83	43.4%	42.2%		62.7%	54.2%
≥200	105	22.9%	18.1%	<0.001	41.0%	32.4%	0.003
Edmondson grading
I-II	142	37.3%	34.5%		55.6%	48.6%
III-IV	46	15.2%	10.9%	<0.001	34.8%	21.7%	0.001
Tumour size (cm)
≤5	69	53.6%	47.8%		73.9%	65.2%
>5	119	19.3%	17.6%	<0.001	37.0%	28.6%	<0.001
Liver cirrhosis
Absent	39	30.8%	25.6%		59.0%	46.2%
Present	149	32.2%	29.5%	0.771	48.3%	40.9%	0.186
Capsulation
Capsulated	130	40.0%	37.7%		60.8%	51.5%
Noncaspulated	58	13.3%	8.6%	<0.001	27.6%	20.7%	<0.001
Tumour number
Single	136	40.4%	36.0%		61.0%	52.9%
Multiple	52	9.6%	9.6%	<0.001	23.1%	13.5%	<0.001
Vascular invasion
Yes	33	3.0%	3.0%		15.2%	6.1%
No	155	38.1%	34.2%	<0.001	58.1%	49.7%	<0.001
GSN
Low expression	93	48.4%	46.2%		61.3%	57.0%
High expression	95	15.8%	11.6%	<0.001	40.0%	27.4%	<0.001

DFS, disease-free survival; OS, overall survival; other abbreviations are as in Table 1.